Riskpilot← Back to searchSign inGet full accessDecursus Oy
OYActiveY-tunnus 3254543-5Eiranranta 7Medical specialists activities · NACE 8622Est. 202131 employees
Revenue 2025
EUR 328K
+1% vs 2024
EBITDA margin
16.1%
+286% vs 2024
Equity ratio
93.8%
Financial strength
Net profit 2025
EUR 42K
+312% vs 2024
| Revenue | EUR 328K | +1% |
| EBITDA | EUR 53K | +286% |
| Net profit | EUR 42K | +312% |
| Total assets | EUR 140K | +34% |
| Equity | EUR 131K | +36% |
| Employees | 31 | — |
Legal name
Decursus Oy
Y-tunnus number
3254543-5
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
14. joulukuuta 2021
Share capital
EUR 0
Employees
31 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Toimitusjohtaja yksin
Company purpose
Lääkäripalvelujen tuottaminen potilaille, alan koulutus- ja konsultointipalvelujen tuottaminen sekä kustannustoiminta.Yhtiö voi omistaa, hallita ja vuokrata kiinteistöjä, liike- ja asuinhuoneistoja sekä kulkuneuvoja. Yhtiö voi harjoittaa arvopaperikauppaa.
Address
Eiranranta 7
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 108 | 359 | 324 | 328 |
| Staff expenses | −55 | −200 | −248 | −207 |
| EBITDA | 28 | 92 | 14 | 53 |
| Depreciation & amort. | — | −0 | −0 | −0 |
| EBIT | 28 | 92 | 14 | 53 |
| Net financials | −0 | −0 | −1 | 0 |
| Profit before tax | 28 | 92 | 13 | 53 |
| Tax | 6 | 18 | 3 | 11 |
| Net profit | 22 | 73 | 10 | 42 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 42 | 122 | 104 | 140 |
| Equity | 22 | 94 | 97 | 131 |
| Long-term debt | — | 0 | 0 | 0 |
| Short-term debt | 19 | 28 | 8 | 9 |
| Total debt | 19 | 28 | 8 | 9 |
EBITDA margin
16.1%
This company
15.8%
Market median
+2% vs market
20222025
Equity ratio
93.8%
This company
38.2%
Market median
+146% vs market
20222025
Return on equity
32.2%
This company
18.4%
Market median
+75% vs market
20222025
Net profit margin
12.9%
This company
8.1%
Market median
+59% vs market
20222025
Asset turnover
2.35×
This company
1.12×
Market median
+110% vs market
20222025
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
20222025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2021-12-01 – 2022-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
MM Chief Executive Officer | Chief Executive Officer | 2021 |
JA | Audit | 2025 |
KK Deputy auditor | Deputy auditor | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Decursus Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Miina Maria Johanna Westman | Chief Executive Officer | 0 companies |
| Jose Adam Juhani Kautonen | Audit | 0 companies |
| Kiri Kasperi Sopanen | Deputy auditor | 0 companies |
| Matti Juhani Westman | Board of Directors | 0 companies |